Home/Filings/4/0001209191-22-043088
4//SEC Filing

SIEGEL RICHARD W 4

Accession 0001209191-22-043088

CIK 0000883107other

Filed

Jul 24, 8:00 PM ET

Accepted

Jul 25, 4:00 PM ET

Size

31.3 KB

Accession

0001209191-22-043088

Insider Transaction Report

Form 4
Period: 2022-07-21
Transactions
  • Award

    Common Stock (right to purchase)

    2021-12-28$4.17/sh+15,000$62,55015,000 total
    Exercise: $4.17From: 2022-12-28Exp: 2028-12-28Common Stock (15,000 underlying)
  • Exercise/Conversion

    Common Stock (right to purchase)

    2022-07-21$0.30/sh10,000$3,0000 total
    Exercise: $0.30From: 2013-08-07Exp: 2022-08-07Common Stock (10,000 underlying)
  • Exercise/Conversion

    Common Stock

    2022-07-21$0.30/sh+10,000$3,000399,838 total
Holdings
  • Common Stock (right to purchase)

    Exercise: $0.44From: 2016-02-18Exp: 2025-02-18Common Stock (9,000 underlying)
    9,000
  • Common Stock (right to purchase)

    Exercise: $0.45From: 2021-06-18Exp: 2027-06-18Common Stock (15,000 underlying)
    15,000
  • Common Stock (right to purchase)

    Exercise: $0.41From: 2014-02-14Exp: 2023-02-14Common Stock (10,000 underlying)
    10,000
  • Common Stock (right to purchase)

    Exercise: $0.99From: 2016-11-17Exp: 2026-11-17Common Stock (2,000 underlying)
    2,000
  • Deferred Common Stock

    Common Stock (20,030 underlying)
    20,030
  • Common Stock (right to purchase)

    Exercise: $0.82From: 2019-05-23Exp: 2028-05-23Common Stock (10,000 underlying)
    10,000
  • Common Stock (right to purchase)

    Exercise: $1.05From: 2016-11-17Exp: 2026-11-17Common Stock (2,000 underlying)
    2,000
  • Common Stock (right to purchase)

    Exercise: $0.84From: 2016-11-17Exp: 2026-11-17Common Stock (2,000 underlying)
    2,000
  • Common Stock (right to purchase)

    Exercise: $0.42From: 2017-02-23Exp: 2026-02-23Common Stock (8,100 underlying)
    8,100
  • Common Stock

    389,838
  • Common Stock (right to purchase)

    Exercise: $1.10From: 2016-11-17Exp: 2026-11-17Common Stock (2,000 underlying)
    2,000
  • Common Stock (right to purchase)

    Exercise: $1.85From: 2016-11-17Exp: 2026-11-17Common Stock (2,000 underlying)
    2,000
  • Common Stock (right to purchase)

    Exercise: $0.52From: 2015-02-13Exp: 2024-02-13Common Stock (10,000 underlying)
    10,000
  • Common Stock (right to purchase)

    Exercise: $0.90From: 2016-11-17Exp: 2026-11-17Common Stock (2,000 underlying)
    2,000
  • Common Stock (right to purchase)

    Exercise: $1.18From: 2016-11-17Exp: 2026-11-17Common Stock (2,000 underlying)
    2,000
  • Common Stock (right to purchase)

    Exercise: $0.68From: 2018-02-21Exp: 2027-02-21Common Stock (10,000 underlying)
    10,000
  • Common Stock (right to purchase)

    Exercise: $0.51From: 2020-05-22Exp: 2029-05-22Common Stock (10,000 underlying)
    10,000
Footnotes (6)
  • [F1]Each share of deferred common stock represents a right to receive one share of common stock.
  • [F2]The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
  • [F3]Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan.
  • [F4]Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments.
  • [F5]Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments.
  • [F6]The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99.

Issuer

NANOPHASE TECHNOLOGIES Corp

CIK 0000883107

Entity typeother

Related Parties

1
  • filerCIK 0001195154

Filing Metadata

Form type
4
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 4:00 PM ET
Size
31.3 KB